1. |
Wernberg JA, Lucarelli DD. Gallbladder cancer. Surg Clin North Am, 2014, 94(2): 343-360.
|
2. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
3. |
Sachs TE, Akintorin O, Tseng J. How should gallbladder cancer be managed? Adv Surg, 2018, 52(1): 89-100.
|
4. |
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6 336 patients and results of a survey. Ann Surg, 2004, 240(2): 205-213.
|
5. |
Kasumova GG, Tabatabaie O, Najarian RM, et al. Surgical management of gallbladder cancer: simple versus extended cholecystectomy and the role of adjuvant therapy. Ann Surg, 2017, 266(4): 625-631.
|
6. |
Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol, 2008, 98(7): 485-489.
|
7. |
Aloia TA, Járufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford), 2015, 17(8): 681-690.
|
8. |
Ethun CG, Postlewait LM, Le N, et al. Association of optimal time interval to re-resection for incidental gallbladder cancer with overall survival: a multi-institution analysis from the US extrahepatic biliary malignancy consortium. JAMA Surg, 2017, 152(2): 143-149.
|
9. |
Ball CG. Damage control surgery. Curr Opin Crit Care, 2015, 21(6): 538-543.
|
10. |
Benz D, Balogh ZJ. Damage control surgery: current state and future directions. Curr Opin Crit Care, 2017, 23(6): 491-497.
|
11. |
Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin, 2010, 60(5): 277-300.
|
12. |
Clark OH, Benson AB 3rd, Berlin JD, et al. NCCN clinical practice guidelines in oncology: neuroendocrine tumors. J Natl Compr Canc Netw, 2009, 7(7): 712-747.
|
13. |
AJCC. Gallbladder (chapter 24)//Zhu AX, Pawlik TM, Kooby DA, et al. AJCC Cancer Staging Manual. 8th edition. New York: Springer, 2018: 303-309.
|
14. |
Shukla SK, Singh G, Shahi KS, et al. Staging, treatment, and future approaches of gallbladder carcinoma. J Gastrointest Cancer, 2018, 49(1): 9-15.
|
15. |
Hawkins WG, DeMatteo RP, Jarnagin WR, et al. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol, 2004, 11(3): 310-315.
|
16. |
Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg, 2000, 232(4): 557-569.
|
17. |
Chan SY, Poon RT, Lo CM, et al. Management of carcinoma of the gallbladder: a single-institution experience in 16 years. J Surg Oncol, 2008, 97(2): 156-164.
|
18. |
Chijiiwa K, Noshiro H, Nakano K, et al. Role of surgery for gallbladder carcinoma with special reference to lymph node metastasis and stage using western and Japanese classification systems. World J Surg, 2000, 24(10): 1271-1276.
|
19. |
Kayahara M, Nagakawa T, Nakagawara H, et al. Prognostic factors for gallbladder cancer in Japan. Ann Surg, 2008, 248(5): 807-814.
|
20. |
Konstantinidis IT, Deshpande V, Genevay M, et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg, 2009, 144(5): 441-447.
|